- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01784263
Schema, Emotion, and Behavior Therapy for Children (SEBASTIEN)
5. september 2018 opdateret af: Jeffrey J. Wood, University of California, Los Angeles
Treatment of Autism Symptoms in Children (TASC): Initial RCT With Active Control
The study is a randomized controlled trial to examine the efficacy of individual cognitive behavioral therapy (CBT) relative to a standard community treatment, in youngsters with autism spectrum disorder (ASD).
The individual CBT program has been tailored over the last five years to the clinical needs of high-functioning youth with ASD.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Autism spectrum disorder (ASD) is among the most common childhood developmental disorders.
A key goal in the field is the discovery of methods that reduce core autism symptoms.
Core autism symptoms include social-cognitive impairments, pragmatic language deficits, and repetitive and rigid behaviors.
The core symptoms tend to be stable and resistant to intervention.
Most treatments involve group-based social skills training (SST), with limited effects.
No treatment for core autism symptoms in school-aged children with ASD meets American Psychological Association guidelines for possible efficacy.
Cognitive behavioral therapy (CBT) offers a novel approach for addressing core autism symptoms in higher functioning school-age youngsters.
Initial results suggest that individual CBT may also be promising for reducing core autism symptoms (Wood et al., 2009b; Drahota, Wood et al., 2011).
The treatment is based on a contemporary model of memory retrieval competition, employing strategies for enhancing the retention of adaptive conceptual and behavioral responses and the suppression of idiosyncratic beliefs and behaviors in daily social contexts, emphasizing the use of deep semantic processing to enhance memory retrieval.
We are proposing a randomized controlled trial to examine the efficacy of individual CBT relative to a standard community treatment in youngsters with ASD.
Undersøgelsestype
Interventionel
Tilmelding
70
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90024
- Jeffrey Wood
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
9 år til 13 år (Barn)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Meets research criteria for a diagnosis of autism, based on child scores on the ADI-R and ADOS tests.
- If taking medication, have maintained a stable dose for 1 month prior to baseline assessment.
- Between the ages of 9-13 years.
- The child's teacher consents to participate in the study to play a modest role in helping implement the intervention and facilitate the school observation assessment.
Exclusion Criteria:
- IQ less than 85.
- The child starts taking new medication(s) or current medication dose changes either (a) less than 1 month prior to the diagnostic evaluation, or (b) during the study period.
- The child is participating in an intensive early intervention program for autism such as applied behavior analysis or floortime.
- For any reason the child or parents appear unable to participate in the treatment program.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Individual Cognitive Behavioral Therapy
|
Therapists will work with families for 32 weekly sessions, each lasting 90 minutes (45 minutes with the child and 45 minutes with the family/parents), implementing the CBT manual for children with ASD (Wood et al., 2007).
|
|
Aktiv komparator: Standard Community Treatment
|
In this condition, the child meets with a therapist for 32 weekly sessions, each 90 minutes.
Therapists use an established manual to administer a standard community treatment.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Playground Observation of Peer Engagement scale
Tidsramme: Post-Treatment (week 32)
|
An independent evaluator-rated school playground observational measure of joint engagement, which is a valid measure of core autism symptoms with established treatment sensitivity
|
Post-Treatment (week 32)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Wood JJ, Kuhfeld M, Sturm A, Cai L, Wood KS, Cornejo Guevara MV, Galan CA, Johnson AR, Cho AC, Weisz JR. Personalized autism symptom assessment with the Youth Top Problems Scale: Observational and parent-report formats for clinical trials applications. Psychol Assess. 2022 Jan;34(1):43-57. doi: 10.1037/pas0001065. Epub 2021 Aug 30.
- Wood JJ, Sze Wood K, Chuen Cho A, Rosenau KA, Cornejo Guevara M, Galan C, Bazzano A, Zeldin AS, Hellemann G. Modular cognitive behavioral therapy for autism-related symptoms in children: A randomized controlled trial. J Consult Clin Psychol. 2021 Feb;89(2):110-125. doi: 10.1037/ccp0000621.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. marts 2012
Primær færdiggørelse (Faktiske)
1. februar 2017
Studieafslutning (Faktiske)
1. september 2017
Datoer for studieregistrering
Først indsendt
23. marts 2012
Først indsendt, der opfyldte QC-kriterier
1. februar 2013
Først opslået (Skøn)
5. februar 2013
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
7. september 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
5. september 2018
Sidst verificeret
1. september 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 11-002061
- 1R01MH094391-01A1 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Autismespektrumforstyrrelse
-
Sohag UniversityTilmelding efter invitationPlacenta Accrete SpectrumEgypten
-
Charite University, Berlin, GermanyRekrutteringSkizofreni Spectrum Disorders (SSD)Tyskland
-
Corestemchemon, Inc.Ikke rekrutterer endnuNeuromyelitis Optica Spectrum Disorder Tilbagefald
-
Kasr El Aini HospitalRekrutteringGraviditet | Apgar score | Tourniquets | Placenta Accrete SpectrumEgypten
-
Novartis PharmaceuticalsAfsluttetPIK3CA-Relateret Overgrowth Spectrum (PROS)Spanien, Frankrig, Australien, Forenede Stater, Irland
-
Assiut UniversityUkendtPlacenta Accrete SpectrumEgypten
-
Kaleido BiosciencesAfsluttetVancomycin-resistente Enterococcus, Extended-Spectrum Beta Lactamase-producerende Enterobacteriaceae eller Carbapenem-resistente Enterobacteriaceae koloniserede forsøgspersonerForenede Stater
-
Jagannadha R AvasaralaAfsluttetMultipel sclerose | Optisk neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Neuromyelitis Optica Spectrum Disorder Tilbagefald | Neuromyelitis Optica Spectrum Disorder ProgressionForenede Stater
-
Hansoh BioMedical R&D CompanyHorizon Therapeutics Ireland DACIkke rekrutterer endnuNeuromyelitis Optica Spectrum DisordersKina
-
RemeGen Co., Ltd.AfsluttetNeuromyelitis Optica Spectrum DisordersKina
Kliniske forsøg med Individual Cognitive Behavioral Therapy
-
Medical University of South CarolinaDrug Abuse Research Training ProgramAfsluttet
-
University Hospital, Clermont-FerrandFondation de l'Avenir, FranceUkendtAfhængighed | Kokain-relaterede lidelserFrankrig
-
University Hospital, Clermont-FerrandNational Cancer Institute, FranceAfsluttetOphør med tobaksbrugFrankrig
-
Universidad Nacional Autonoma de MexicoIstituto Auxologico Italiano; Medica Sur Clinic & FoundationUkendt
-
M.D. Anderson Cancer CenterRekrutteringDepression | Kræft | Træthed | Søvn | AngstForenede Stater
-
Jack Edinger, PhDNational Institute of Mental Health (NIMH); National Institutes of Health...AfsluttetPrimær søvnløshed | Insomnia Comorbid til psykiatrisk lidelseForenede Stater, Canada